Venture
![Screen Shot 2019-08-01 at 2.24.13 PM Screen Shot 2019-08-01 at 2.24.13 PM](https://firstxfounder.com/wp-content/uploads/2019/08/Screen-Shot-2019-08-01-at-2.24.13-PM.png)
Affiliations
University of Connecticut
Technologies
Therapeutic
Indication
Autoimmune & Inflammation
Drug Discovery
Oncology
Personalized Medicine
Website
demaybiotech.comAdditional Information
Women Founded
DeMay Bio is developing a biologic drug for Rheumatoid Arthritis that leverages a natural human protein to target a novel, but validated, disease mechanism directly in the joints. The new drug is an adjunct therapy, to be used alongside a patient’s immunosuppressant regimen, to achieve better disease control, and to reduce disabling joint pain, tissue damage and mobility loss.
DeMay Bio Team: